Human immunodeficiency virus, atherosclerosis and Chlamydophila pneumoniae

Figure 1 In the patient co infected with human immunodeficiency virus /chlamydia, under highly active antiretroviral therapy, a factor of risk can occur to develop lipodystrophy and other disorders of the metabolism of lipids as dyslipidemia or hipertriglyceridemia, conducting finally to atherosclerosis. Thus same, in patients with re infections and obesity, would be able to occur an activation in the mechanism of inflammation that has an important role in the pathogenesis of atherosclerosis resulting in a cycle of inflammation, activation and continuous cell recruitment.